Plant ID: NPO23044
Plant Latin Name: Aesculus hippocastanum
Taxonomy Genus: Aesculus
Taxonomy Family: Sapindaceae
NCBI TaxonomyDB:
43364
Plant-of-the-World-Online:
n.a.
Alterative; Analgesic; Antiinflammatory; Antirheumatic; Astringent; Bach; Diuretic; Expectorant; Febrifuge; Haemostatic; Narcotic; Tonic; Vasoconstrictor; Vulnerary
Turkey; Italy; India; Lebanon; China; Bulgaria
CA2; CA1; CA12; CA9; CA13; CA14; CA7; CA3; CA5B; CA5A; CA4; CA6; | |
ESR2; | |
HPGD; HSD17B10; ALOX15; ALDH1A1; | |
CASP1; CASP7; | |
HIF1A; | |
HTT; | |
XDH; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA13 | Carbonic anhydrase XIII | Q8N1Q1 | CHEMBL3912 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.251E-11 | 2.477E-08 | CA1, CA12, CA13, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 5.234E-35 | 1.140E-30 | CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.393E-27 | 2.605E-23 | CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.199E-25 | 6.527E-22 | CA1, CA12, CA13, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.712E-06 | 4.255E-03 | CA2, CA7 |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 1.852E-05 | 1.754E-02 | ALOX15, HPGD |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.852E-05 | 1.754E-02 | CA1, CA2 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 5.316E-05 | 4.823E-02 | CA2, CA4, CA9, HPGD |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 5.542E-05 | 4.827E-02 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 4.684E-34 | 1.827E-32 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14, CA13 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 2.882E-04 | 5.619E-03 | CA2, CA4 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.656E-03 | 2.152E-02 | CASP7, CASP1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 3.053E-03 | 2.977E-02 | CASP7, CASP1 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 1.451E-02 | 9.432E-02 | CASP7, HSD17B10 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00280 | Valine, leucine and isoleucine degradation | 5.152E-02 | 1.389E-01 | HSD17B10 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 3.144E-02 | 1.389E-01 | ALOX15 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 4.942E-02 | 1.389E-01 | XDH |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04150 | mTOR signaling pathway | 6.399E-02 | 1.389E-01 | HIF1A |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 5.488E-03 | 4.281E-02 | XDH |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
NA: NA | Edema | NA | CA2; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |